» Articles » PMID: 12118892

Prevention of Post-transplant Cardiovascular Disease--report and Recommendations of an Ad Hoc Group

Citing Articles

Dyslipidemia in Transplant Patients: Which Therapy?.

Iannuzzo G, Cuomo G, Di Lorenzo A, Tripaldella M, Mallardo V, Iaccarino Idelson P J Clin Med. 2022; 11(14).

PMID: 35887846 PMC: 9318180. DOI: 10.3390/jcm11144080.


Development and future deployment of a 5 years allograft survival model for kidney transplantation.

Dubay D, Su Z, Morinelli T, Baliga P, Rohan V, Bian J Nephrology (Carlton). 2018; 24(8):855-862.

PMID: 30198104 PMC: 6408984. DOI: 10.1111/nep.13488.


Medical Management of Metabolic Complications of Liver Transplant Recipients.

Barnard A, Konyn P, Saab S Gastroenterol Hepatol (N Y). 2016; 12(10):601-608.

PMID: 27917074 PMC: 5114502.


Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes.

Venuto R, Meaney C, Chang S, Leca N, Consiglio J, Wilding G Medicine (Baltimore). 2015; 94(37):e1315.

PMID: 26376376 PMC: 4635790. DOI: 10.1097/MD.0000000000001315.


Early steroid withdrawal regimen prevents new-onset diabetes mellitus in old-age recipients after living donor liver transplantation.

Kim Y, Lee K, Kim S, Cho S, Han S, Park S World J Surg. 2012; 36(10):2443-8.

PMID: 22674089 DOI: 10.1007/s00268-012-1661-6.